Two major exchange groups are launching futures markets for computing power. The financialization of GPU compute transforms an opaque operational cost into a tradeable commodity with deep implications for institutional portfolios.
Pixxel’s six Firefly satellites combined with Aurora AI are turning orbital hyperspectral data into ranked mineral exploration targets. The NRO just validated the technology.
Autonomous AI agents can now discover, chain, and exploit vulnerabilities in minutes — work that took human pentesters weeks. XBOW’s $120M Series C and #1 HackerOne ranking signal a category shift.
mbiomics closes €30M Series A for AI/ML-designed microbial consortia — a new class of live biotherapeutic products that could reshape how metabolic and immune diseases are treated.
Quantum Systems' $1.2B Series D is the clearest signal yet that sovereign and institutional capital is moving from LP commitments to direct equity in defence and dual-use deep tech — with implications for the entire asset class.
A security officer in Kyiv gets an alert on a tablet: the air at a checkpoint 300 metres away just tested positive for a chemical agent. No one had to go near it. The detector, a protein-engineered biosensor the size of a deck of cards mounted on a quadcopter,
Pension funds, SWFs, and private equity are treating defence-adjacent technology as a new asset class. The fund structures being built for it did not exist three years ago.
NIH awards Locus Biosciences $3.3M for Phase 1b trial of AI-designed bacteriophage therapy against antibiotic-resistant Pseudomonas aeruginosa hospital-acquired pneumonia.
Get daily updates on the technologies and investment opportunities shaping the next decade — from AI infrastructure and autonomous systems to biotech, space, and defence. Curated analysis, no noise.
